Gates Package — page 739

From: Trevor Mundel HR 2 «2s foundation.org> To: "Conrad, Patricia (NIH/NIAID) [E]" [J Qniaid nin. gov> Ce: "Lane, Cliff 1D) [E]" HB oniaia. nih. gov> Christa Bowles )gatesfoundation.org>, Mike Poole BE 6 «21s foundation.org> Subject: Re: on behalf of Dr. Fauci Date: Wed, 15 Apr 2020 14:43:01 -0400 Importance: Normal Thanks Pat, hi Cliff we were just on a call with Tony and Bill and they agreed that we should look at how we might coordinate our activities in the plasma trial space as we are working with the same consortium to see if recruitment of donors and the actual trial might be accelerated. As we're more focused on post-exposure prophylaxis and treatment of mild high risk cases to prevent progression there might be some synergies with your focus. I'm copying in my colleague Mike Poole who is leading our efforts and though we might get together on a call soon. Trevor Trevor Mundel, MD, PhD President, Global Health Program Vv FE E )gatesfoundation.org Christa Bowles Executive Assistant Office of the President, Global Health Vl M E gatesfoundation.org Bill & Melinda Gates Foundation www.gatesfoundation.org From: Conrad, Patricia (NIH/NIAID) [£] [EMO niaid.nih.gov> Sent: Wednesday, April 15, 2020 9:34:23 AM To: Trevor Mundel gatesfoundation.org> Ce: Lane, Cliff (NIH/NIAID) [E] niaid.nih.gov>; Christa Bowles [BEEBE gatesfoundation.org> Subject: on behalf of Dr. Fauci Per the call today with Mr. Gates -- am adding Dr. Lane here so that you can connect and follow up. Please let me know if you need anything else from me -- always happy to help. Best regards, Patricia L. Conrad Public Health Analyst and Special Assistant to the Director National Institute of Allergy and Infectious Diseases The National Institutes of Health